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| INTRODUC TI ON
Pancreatic ductal adenocarcinoma is the fourth leading cause of cancer-related death in the United States. Pancreatic ductal adenocarcinoma is a highly invasive and metastatic malignancy; less than 20% of cases are localized and thus potentially curable. 1, 2 The EMT, which involves fundamental changes in gene expression that disrupt epithelial polarity and establish a mesenchymal phenotype, can be induced by TGF-β. 3 The zinc finger transcription factor Snail is upregulated by TGF-β and could be a key inducer of the EMT. 4 In cancers, this process is involved in resistance to cell death, senescence, chemotherapy, and immunotherapy. 5 Although the EMT can trigger invasion and metastasis of several cancers, including PDAC, 6 the regulatory mechanisms by which EMT pathways are regulated in PDAC are unclear.
Long noncoding RNAs are defined as nonprotein-coding RNAs more than 200 nucleotides in length. Long noncoding RNAs have been implicated in the regulation of gene expression and the pathogenesis of various diseases, including cancers. Some lncRNAs, such as H19, HULC, MALAT-1, and HOTAIR, were reported to be highly expressed, and to function as oncogenic lncRNAs, in several cancers. 7, 8 Other lncRNAs are being increasingly recognized to contribute to biological processes through diverse mechanisms in PDAC.
HOTAIR was reported to be a negative prognostic factor, and to regulate cell proliferation, the cell cycle, and apoptosis in PDAC. 9 MALAT-1 decreased the sensitivity to chemotherapy and accelerated tumor angiogenesis by enhancing stem cell-like phenotypes in PDAC. 10 HOTTIP was also found to promote PDAC cell proliferation and invasion by regulating HOXA13. 11 Although several other lncRNAs, such as H19, GAS5, and PVT1, are related to PDAC development, the role of lncRNAs in the EMT pathway in PDAC is not well understood. [12] [13] [14] Moreover, the interrelationship between 2 classes of ncRNA, lncRNAs and miRNAs, reportedly contributes to the epigenetic regulation of gene expression in several diseases. 15 Thus, there is a need to identify lncRNAs and miRNAs that regulate the EMT, and elucidate the underlying regulatory mechanisms, in human PDAC.
Extracellular vesicles, such as microvesicles and exosomes, are membranous vesicles released by most cells. 16 Extracellular vesicles contain proteins, lipids, and RNAs from donor cells, can be taken up by, and transfer their contents to, recipient cells, and modulate recipient cell behavior. [17] [18] [19] [20] Noncoding RNAs are also contained and carried by EVs. Although several miRNAs are transferred by EVs, the mechanisms of intercellular transfer of lncRNA in EVs are unclear. We have previously reported that lncRNAs, such as linc-RoR and linc-VLDLR, can be carried by EVs and modulate signaling pathways related to resistance to chemotherapy or hypoxic stress in recipient hepatocellular cancer cells. 21, 22 Based on these findings, we hypothesized that intercellular signaling by EV lncRNAs mediates tumor cell invasion and metastasis by regulating the EMT pathway in human PDAC.
Although CA19-9 and CEA are currently used as clinical biomarkers for human PDAC, they are insufficient for its diagnosis, particularly at an early stage. 23 Recently, circulating tumor cells, cell-free DNA, and EVs (including exosomes) have been evaluated in terms of liquid biopsy. Liquid biopsy constitutes a promising noninvasive alternative to traditional tissue biopsy for diagnosis and monitoring of the evolution and therapeutic response of a tumor. 24 Although EV-encapsulated small ncRNAs reportedly modulate cancer cell behavior and/or serve as biomarkers for cancers, there is very limited information regarding lncRNAs in this context.
In this study, we aimed to identify lncRNAs involved in the EMT pathway and investigate their functional roles during PDAC cell invasion and migration. Moreover, we identified miRNAs that negatively regulate lncRNAs and revealed the contribution of the interrelationship between lncRNAs and miRNAs to the regulatory mechanisms of PDAC development. Furthermore, we identified an lncRNA in serum EVs that could serve as a novel biomarker for human PDAC.
| MATERIAL S AND ME THODS

| Cell lines, culture, and reagents
The nonmalignant human pancreatic ductal epithelial cell line hTERT-HPNE was obtained from ATCC and cultured as recommended by the supplier. The human pancreatic cancer cell lines Panc-1, MiaPaCa-2, and BxPC-3 were obtained from ATCC, and KP-3 and QGP-1 were purchased from the JCRB Cell Bank. Panc-1 cells were cultured in high-glucose DMEM (Thermo Fisher Scientific) containing 10% FBS and 1% penicillin-streptomycin (Thermo Fisher Scientific). MiaPaCa-2 cells were cultured in high-glucose DMEM containing 10% FBS, 2.5% horse serum, and 1% penicillinstreptomycin. BxPC-3, KP-3, and QGP-1 cells were cultured in RPMI-1640 medium (Thermo Fisher Scientific) containing 10% FBS and 1% penicillin-streptomycin. All cells were cultured at 37°C in an atmosphere containing 5% CO 2 . For all EV studies, EV-depleted medium was prepared using exosome-depleted FBS (Thermo Fisher Scientific). Transforming growth factor-β was obtained from EMD Millipore. Cells were treated with 10 ng/mL TGF-β for 72 hours to induce the EMT. Table 1 .
| Human samples
Other materials and methods are described in Data S1. 
| RE SULTS
| High expression of HULC in PDAC cells and expression induced by TGF-β
Transforming growth factor-β induces the EMT pathway, which triggers invasion and metastasis in several cancers. To investigate whether TGF-β induces the EMT in PDAC cells, we examined the expression of EMT-related genes and morphological changes after incubation with 10 ng/mL TGF-β. Epithelial-mesenchymal transition is associated with the downregulation of epithelial markers and the upregulation of mesenchymal markers at the molecular level. We verified that the epithelial marker E-cadherin was downregulated, and that the EMT-inducible transcription factor Snail, and the mesenchymal markers N-cadherin and vimentin were upregulated, in TGF-β-treated PDAC cells ( Figure S1A ). As the EMT is morphologically characterized by changes from an epithelial cell phenotype to a spindle-like appearance, and functionally characterized by decreased cell adhesion, we also confirmed that PDAC cells became spindle shaped and grew in isolation after TGF-β treatment ( Figure S1B ).
Next, to identify lncRNAs induced by TGF-β in PDAC, we examined the expression profiles of 90 known lncRNAs in Panc-1 PDAC cells after incubation with or without TGF-β by RT-qPCR.
We identified several lncRNAs with greater than 0.5 log 2 (fold change) alteration in expression in Panc-1 cells treated with TGF-β compared to the control ( Figure 1A ). We next analyzed the expression of lncRNAs in EVs derived from Panc-1 cells after TGF-β treatment. Compared to control EVs (derived from Panc-1 cells incubated without TGF-β), the expression of 21 lncRNAs was increased by more than 0.5 log 2 (fold change) in EVs derived from Panc-1 cells treated with TGF-β ( Figure 1B ). These included 6 deregulated lncRNAs in TGF-β-treated Panc-1 cells ( Figure 1C ).
Among them, HULC was the only lncRNA whose expression was induced by TGF-β in a panel of pancreatic cancer cells ( Figure 1D) and altered by 1.7-to 4.7-fold in several pancreatic cancer cells compared to values in hTERT-HPNE normal pancreatic epithelial TA B L E 1 (Continued) cells ( Figure 1E ). Thus, we focused on HULC as a candidate EMTrelated, as well as oncogenic, lncRNA.
| Knockdown of HULC attenuates cell invasion and migration by inhibiting the EMT in PDAC cells
Having identified HULC as a TGF-β-regulated and candidate EMTrelated lncRNA, we next assessed its role in the EMT pathway.
First, we confirmed the efficiency of HULC siRNAs and used them in further experiments. The mRNA level of the EMT-inducible transcription factor Snail was reduced by HULC knockdown compared to the control. An siRNA to HULC also decreased the N-cadherin and vimentin mRNA levels, whereas it increased that of E-cadherin, in Panc-1 and MiaPaCa-2 cells (Figure 2A and Figure   S2 ). Consistent with these changes, the N-cadherin, vimentin, and Snail protein levels were decreased, and that of E-cadherin was increased, by HULC knockdown ( Figure 2B ). Moreover, cells transfected with an siRNA to HULC showed significantly reduced proliferation, viability, invasion, and migration ( Figure 2C -F). Therefore, HULC is a TGF-β-inducible lncRNA that is aberrantly expressed in tumor cells and can modulate PDAC cell phenotypes in part by regulating the EMT pathway. 
| Tumor cell growth modulated by HULC suppressing EMT in vivo
| Extracellular HULC transfer can promote PDAC cell invasion and migration
Extracellular vesicle contents are transferred from donor to recipient cells. We have reported that EV-mediated transfer of lncRNAs can modulate the behavior of neighboring HCC cells. 21, 22 Thus, we 
| HULC is a direct target of miR-133b
The interrelationship between 2 classes of ncRNAs, miRNAs and lncRNAs, reportedly contributes to epigenetic regulation in several cancers. 25 Therefore, to reveal the regulatory mechanisms of HULC, we identified candidate miRNAs that target HULC and are downregulated by TGF-β. We postulated that candidate tumor-suppressing miRNAs would suppress EMT signaling by targeting HULC.
A microarray analysis identified 187 miRNAs whose expression was decreased by less than 0.87-fold in Panc-1 cells treated with TGF-β ( Figure 5A,B ). Of these, miR-133b was predicted to target HULC by a bioinformatics analysis on miRNA.org ( Figure 5C ). Moreover, miR-133b expression was reduced by TGF-β in a panel of pancreatic cancer cells ( Figure 5D ). The posttranscriptional regulation of gene expression by miRNAs is the result of their complementary binding to the 3′-UTR of their RNA targets. 26 Bioinformatics analysis predicted that HULC has a 7-nucleotide miR-133b binding site. Therefore, to determine whether HULC is a direct target of miR-133b, we cotransfected a miR-133b mimic and a firefly luciferase reporter vector containing the target site of HULC into Panc-1 and MiaPaCa-2 cells.
The HULC firefly luciferase activity was significantly decreased in miR-133b-overexpressing cells ( Figure 5E ), confirming the specificity of the interaction between miR-133b and HULC. Based on these results, we focused on miR-133b as a candidate EMT-suppressing miRNA in further experiments.
| MicroRNA-133b suppresses cell invasion and migration by inhibiting EMT by targeting HULC
To assess whether miR-133b suppresses cell invasion and migration by targeting HULC, we next investigated the functional contribution of miR-133b to the EMT pathway. We used a miRNA mimic to overexpress miR-133b and confirmed its effect on miR-133b by qPCR.
The miR-133b mimic decreased HULC expression in PDAC cells.
MicroRNA-133b overexpression significantly reduced N-cadherin, vimentin, and Snail expression, and increased that of E-cadherin ( Figure 6A,B) . Also, overexpression of miR-133b decreased cell proliferation, viability, invasion, and migration ( Figure 6C -F).
To further evaluate the impact of miR-133b on the EMT, a miR-133b inhibitor was used to attenuate miR-133b activity in PDAC cells. We assessed the expression levels of EMT-related genes in Panc-1 cells after incubation with the miR-133b inhibitor. Inhibition of miR-133b significantly increased HULC, N-cadherin, vimentin, and Snail expression, and decreased that of E-cadherin ( Figure S3A,B ).
We next analyzed tumor cell behavior after miR-133b inhibition. The miR-133b inhibitor significantly increased the proliferation, viability, invasion, and migration of PDAC cells ( Figure S3C-F) . Therefore, miR-133b suppressed PDAC cell invasion and migration by inhibiting the EMT through targeting HULC.
| Extracellular vesicle-encapsulated HULC derived from serum is a potential biomarker for human PDAC
Finally, we investigated the potential of EV HULC as a novel biomarker for human PDAC. Serum samples from 20 PDAC patients, F I G U R E 2 Effect of HULC knockdown on the epithelial-mesenchymal transition and phenotype of pancreatic ductal adenocarcinoma cells. Panc-1 cells were transfected with an siRNA to HULC 1, HULC 2, or a control siRNA. A, After 48 h, RNA was isolated and quantitative PCR for HULC, E-cadherin, N-cadherin, vimentin, and Snail was carried out. B, After 72 h, protein was extracted and western blotting was carried out using Abs against E-cadherin, N-cadherin, vimentin, and Snail. Relative expression normalized to that of β-actin is shown. C-F, Panc-1 cells were transfected with an siRNA to HULC 1, HULC 2, or a control siRNA. C,D, After 24, 48, 72, and 96 h, cell proliferation was examined by cell counting using Trypan blue (C) and cell viability was examined by MTS assay (D Figure 7A,B) . Moreover, analysis using only PDAC patient samples showed that there was no significant correlation between EV HULC expression and stage, N factor, M factor, or the other clinical factors analyzed ( Figure 7C) . A receiver operating characteristic curve was plotted to assess the diagnostic performance of EV HULC expression, CA19-9, and CEA for PDAC. Extracellular and 0.54, respectively, and there was no significant difference in the AUC between HULC and CA19-9 ( Figure 7D ). These results suggest that HULC performs similarly to CA19-9 as a potential biomarker for human PDAC, particularly for predicting the malignant potential of IPMN. was correlated with HOXA13 expression in tumor tissue. 11 TUG1 promotes cell migration and contributes to the EMT in PDAC cells. 31 In this study, we found that HULC expression is induced by TGF-β and promotes cell invasion and migration by regulating the EMT pathway in PDAC cells. Thus, HULC is a potential oncogenic gene in human PDAC, as in other gastroenterological cancers. Recently, the interrelationship between miRNAs and lncRNAs has been reported to contribute to the epigenetic regulation of gene expression in several diseases. 15 HULC is a target of miR-488. MicroRNA-488 suppressed cell invasion by inhibiting the EMT pathway through targeting ADAM9, and attenuated cell proliferation by inhibiting HULC expression through sponging to HULC in HCC cells. 32 Our study revealed that miR-133b targets HULC directly and attenuates PDAC cell invasion and migration by inhibiting HULC expression. These results provide new insights into the Circulating nucleic acids, including mRNAs and ncRNAs, can be useful for liquid biopsy, which can provide diagnostic and prognostic information. Circulating EVs have potential for liquid biopsy because they can transport cargo, such as mRNAs, ncRNAs, and proteins. 33, 34 There are few reports regarding liquid biopsy using circulating EV lncRNAs. 35 For instance, CRNDE-h is expressed in CRC tissue. The serum exosomal CRNDE-h level was elevated and could serve as a diagnostic and prognostic biomarker for CRC. 36 Long noncoding RNA H19 is highly expressed in HCC tissue, mainly in cholangiocytes. Cholangiocytederived exosome-mediated transfer of H19 promotes cholestatic injury in hepatocytes. Moreover, the serum exosomal H19 level gradually increased during liver injury in a mouse model. 37 The potential of EV lncRNA as a biomarker for pancreatic cancer is unclear. In this study, EV HULC was highly expressed in the serum of PDAC patients; the AUC was comparable to that of CA19-9. Moreover, EV HULC might enable detection of early PDAC in IPMN patients. Although the limitation of this study is the small number of samples, and further analysis of the usefulness of EV HULC for liquid biopsy using a greater number of samples is warranted, our data suggest that EV HULC has potential as a biomarker for early diagnosis of human PDAC.
| D ISCUSS I ON
We evaluated the role of EV lncRNA-miRNA signaling in tumor invasion and migration in PDAC cells, and identified EV-encapsulated lncRNA as a biomarker for PDAC ( Figure 8 ). These findings provide mechanistic insights into cancer cell invasion and metastasis, identify novel therapeutic targets for cancer, and suggest the potential of EV HULC for early diagnosis of PDAC.
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